These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23647563)

  • 1. Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials.
    Irwin NJ; McCoy CP; Carson L
    J Appl Microbiol; 2013 Aug; 115(2):382-9. PubMed ID: 23647563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    J Antibiot (Tokyo); 2013 Oct; 66(10):593-7. PubMed ID: 23801185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Proteus mirabilis distribution in multi-species biofilms on urinary catheters and determination of bacteria resistance to antimicrobial agents.
    Moryl M; Torzewska A; Jałmuzna P; Rózalski A
    Pol J Microbiol; 2013; 62(4):377-84. PubMed ID: 24730132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.
    Kwiecińska-Piróg J; Skowron K; Zniszczol K; Gospodarek E
    Biomed Res Int; 2013; 2013():930876. PubMed ID: 24151628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ureolytic Biomineralization Reduces Proteus mirabilis Biofilm Susceptibility to Ciprofloxacin.
    Li X; Lu N; Brady HR; Packman AI
    Antimicrob Agents Chemother; 2016 May; 60(5):2993-3000. PubMed ID: 26953206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis.
    Aiassa V; Barnes AI; Albesa I
    Biochem Biophys Res Commun; 2010 Feb; 393(1):84-8. PubMed ID: 20097163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.
    Wasfi R; Abd El-Rahman OA; Mansour LE; Hanora AS; Hashem AM; Ashour MS
    Indian J Med Microbiol; 2012; 30(1):76-80. PubMed ID: 22361765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.
    Fàbrega A; Soto SM; Ballesté-Delpierre C; Fernández-Orth D; Jiménez de Anta MT; Vila J
    J Antimicrob Chemother; 2014 Jul; 69(7):1815-24. PubMed ID: 24706735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fluoroquinolones and antioxidans on biofilm formation by Proteus mirabilis strains.
    Przekwas J; Gębalski J; Kwiecińska-Piróg J; Wiktorczyk-Kapischke N; Wałecka-Zacharska E; Gospodarek-Komkowska E; Rutkowska D; Skowron K
    Ann Clin Microbiol Antimicrob; 2022 Jun; 21(1):22. PubMed ID: 35655208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.
    Hawkey PM; Hawkey CA
    J Antimicrob Chemother; 1984 Nov; 14(5):485-9. PubMed ID: 6511707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allicin from garlic inhibits the biofilm formation and urease activity of Proteus mirabilis in vitro.
    Ranjbar-Omid M; Arzanlou M; Amani M; Shokri Al-Hashem SK; Amir Mozafari N; Peeri Doghaheh H
    FEMS Microbiol Lett; 2015 May; 362(9):. PubMed ID: 25837813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.
    Shimizu T; Harada K
    Microbiol Immunol; 2017 Jan; 61(1):17-22. PubMed ID: 28042660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some observations on the diffusion of antimicrobial agents through the retention balloons of foley catheters.
    Williams GJ; Stickler DJ
    J Urol; 2007 Aug; 178(2):697-701. PubMed ID: 17574612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antivirulence activity of sub-inhibitory concentrations of ciprofloxacin against Proteus mirabilis isolates: an in-vitro and in-vivo study.
    Elhosseini MA; El-Banna TE; Sonbol FI; El-Bouseary MM
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):48. PubMed ID: 38802894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activity of weak organic acids against uropathogens.
    Burns J; McCoy CP; Irwin NJ
    J Hosp Infect; 2021 May; 111():78-88. PubMed ID: 33545217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
    Maszewska A; Zygmunt M; Grzejdziak I; Różalski A
    J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators, metabolic status or active pump proteins.
    Aygül A; Öztürk İ; Çilli FF; Ermertcan Ş
    Phytomedicine; 2019 Apr; 57():65-71. PubMed ID: 30668324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.